跳至主要内容
临床试验/NCT00734604
NCT00734604已完成3 期

A Comparison of Psychosocial Outcomes Following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men With Erectile Dysfunction.

Eli Lilly and Company1 个研究点 分布在 1 个国家目标入组 378 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
378
试验地点
1
主要终点
Change From Baseline Between Tadalafil Once a Day (OaD) and Sildenafil as Needed (PRN) in Sexual Self-Confidence Domain of Psychological and Interpersonal Relationship Scales (PAIRS)

研究概览

简要总结

The primary purpose of the study is to help answer whether tadalafil taken once a day can help improve the psychological outcomes (such as sexual self confidence, spontaneity and time concerns) compared to sildenafil taken as needed in patients with erectile dysfunction (ED).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • History of erectile dysfunction (ED).
  • Have had satisfactory response to tadalafil, sildenafil citrate, or vardenafil HCl for a period of at least 6 months and expect frequent use (at least one dose per week, on average) when administered as needed.
  • Have never used tadalafil 5 mg or 2.5 mg once a day therapy.
  • Anticipate having the same adult female sexual partner willing to participate during the study.
  • Agree to make at least four sexual intercourse attempts during the first four weeks of the study.
  • Agree not to use any other treatment for ED (even herbal treatments) during the study.
  • Agree to follow the directions given by the study doctor and staff about using the study drug.

排除标准

  • Have any other primary sexual disorders present or penile deformity.
  • Have history of radical prostatectomy or penile implant.
  • Have problems with your kidneys, liver, or nervous system.
  • Have uncontrolled diabetes, as measured by a blood test for haemoglobin A1C greater than a value of 11%.
  • Are being treated for heart disease with any drug that is called a nitrate (for example, nitroglycerin).
  • Have chest pain (called unstable angina or angina) that requires treatment.
  • Have heart disease that causes symptoms after you exert yourself.
  • Have had any of the following in the past 90 days: Heart attack, also known as a myocardial infarction (MI); Heart bypass surgery (called coronary artery bypass graft surgery); Had a procedure to open up blood vessels in the heart known as angioplasty or stent placement (percutaneous coronary intervention).
  • Have a history of loss of vision in one eye because of nonarteritic anterior ischemic optic neuropathy (NAION).
  • Have retinitis pigmentosa.
  • Have history of human immunodeficiency virus (HIV).
  • Have very high or very low blood pressure (your study doctor will discuss the limits with you).
  • Have had a stroke or a significant injury to your brain or spinal cord within the last 6 months.
  • Have rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption Lactose intolerance.
  • Have a scheduled or planned surgery requiring anaesthesia during the course of the study.
  • Have a scheduled cataract surgery during the curse of the study.

研究组 & 干预措施

T(OaD)/S(PRN)/T(PRN)

Experimental

Tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks

干预措施: tadalafil once a day [T(OaD)] (Drug)

T(OaD)/S(PRN)/T(PRN)

Experimental

Tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks

干预措施: sildenafil citrate as needed [S(PRN)] (Drug)

T(OaD)/S(PRN)/T(PRN)

Experimental

Tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks

干预措施: tadalafil as needed [T(PRN)] (Drug)

T(OaD)/T(PRN)/S(PRN)

Experimental

Tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks

干预措施: tadalafil once a day [T(OaD)] (Drug)

T(OaD)/T(PRN)/S(PRN)

Experimental

Tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks

干预措施: sildenafil citrate as needed [S(PRN)] (Drug)

T(OaD)/T(PRN)/S(PRN)

Experimental

Tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks

干预措施: tadalafil as needed [T(PRN)] (Drug)

S(PRN)/T(OaD)/T(PRN)

Experimental

Sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks

干预措施: tadalafil once a day [T(OaD)] (Drug)

S(PRN)/T(OaD)/T(PRN)

Experimental

Sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks

干预措施: sildenafil citrate as needed [S(PRN)] (Drug)

S(PRN)/T(OaD)/T(PRN)

Experimental

Sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks

干预措施: tadalafil as needed [T(PRN)] (Drug)

S(PRN)/T(PRN)/T(OaD)

Experimental

Sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks

干预措施: tadalafil once a day [T(OaD)] (Drug)

S(PRN)/T(PRN)/T(OaD)

Experimental

Sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks

干预措施: sildenafil citrate as needed [S(PRN)] (Drug)

S(PRN)/T(PRN)/T(OaD)

Experimental

Sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks

干预措施: tadalafil as needed [T(PRN)] (Drug)

T(PRN)/T(OaD)/S(PRN)

Experimental

Tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks

干预措施: tadalafil once a day [T(OaD)] (Drug)

T(PRN)/T(OaD)/S(PRN)

Experimental

Tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks

干预措施: sildenafil citrate as needed [S(PRN)] (Drug)

T(PRN)/T(OaD)/S(PRN)

Experimental

Tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks

干预措施: tadalafil as needed [T(PRN)] (Drug)

T(PRN)/S(PRN)/T(OaD)

Experimental

Tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks

干预措施: tadalafil once a day [T(OaD)] (Drug)

T(PRN)/S(PRN)/T(OaD)

Experimental

Tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks

干预措施: sildenafil citrate as needed [S(PRN)] (Drug)

T(PRN)/S(PRN)/T(OaD)

Experimental

Tadalafil 20 mg as needed [T(PRN)] for 8 weeks, 1 week washout, sildenafil citrate 100 mg as needed [S(PRN)] for 8 weeks, 1 week washout, tadalafil 5 mg once a day [T(OaD)] for 8 weeks

干预措施: tadalafil as needed [T(PRN)] (Drug)

结局指标

主要结局

Change From Baseline Between Tadalafil Once a Day (OaD) and Sildenafil as Needed (PRN) in Sexual Self-Confidence Domain of Psychological and Interpersonal Relationship Scales (PAIRS)

时间窗: baseline, 8 weeks of each treatment

The PAIRS is a self-administed scale that assesses the broader psychological and interpersonal outcomes associated with erectile dysfunction and its treatment. Sexual Self-Confidence score is the average of responses on 6 PAIRS item scores. Sexual Self-Confidence scores range from 1 (strongly disagree) to 4 (strongly agree). Higher scores are indicative of greater sexual self-confidence.

次要结局

  • Change From Baseline Between Tadalafil Once a Day (OaD) and Tadalafil as Needed (PRN) in Sexual Self-Confidence Domain of Psychological and Interpersonal Relationship Scales (PAIRS)(baseline, 8 weeks of each treatment)
  • Change From Baseline to Endpoint in the Spontaneity Domain of PAIRS(baseline, 8 weeks of each treatment)
  • Change From Baseline to Endpoint in the Time Concerns Domain of PAIRS(baseline, 8 weeks of each treatment)
  • Change From Baseline to Endpoint in the Erectile Function Domain of the International Index of Erectile Function (IIEF)(baseline, 8 weeks of each treatment)
  • Change From Baseline to Endpoint in the Proportion of Days With at Least One Morning Erection(baseline, 8 weeks of each treatment)
  • Change From Baseline to Endpoint in the Intercourse Satisfaction (IS) Domain of the IIEF(baseline, 8 weeks of each treatment)
  • Change From Baseline to Endpoint in the Overall Satisfaction (OS) Domain of the IIEF(baseline, 8 weeks of each treatment)
  • Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Score at Endpoint(8 weeks of each treatment)
  • Number of Participants With at Least One Serious Adverse Event(baseline through 26 weeks (including two washout periods of 1 week each))
  • Change From Baseline to Endpoint in the Self-Esteem And Relationship (SEAR) Questionnaire Transformed Total Score(baseline, 8 weeks of each treatment)
  • Question 1 "I Felt as if I Did Not Have ED" Score of the Patient Perception and Feelings Questions (PPF-Q) at Endpoint(8 weeks of each treatment)
  • Question 3 "I Felt the Drug Was in Control of my Erections" Score of the Patient Perception and Feelings Questions (PPF-Q) at Endpoint(8 weeks of each treatment)
  • Question 2 "I Felt in Control of my Sex Life" Score of the Patient Perception and Feelings Questions (PPF-Q) at Endpoint(8 weeks of each treatment)
  • Question 4 "I Felt Like a Whole Man" Score of the Patient Perception and Feelings Questions (PPF-Q) at Endpoint(8 weeks of each treatment)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验